WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2001005428) PREVENTIVES FOR THE RECURRENCE OF CEREBROVASCULAR FAILURE AND AGENTS FOR AMELIORATING TROUBLES FOLLOWING CEREBROVASCULAR FAILURE AND INHIBITING PROGRESS THEREOF
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2001/005428    International Application No.:    PCT/JP2000/004830
Publication Date: 25.01.2001 International Filing Date: 19.07.2000
Chapter 2 Demand Filed:    23.08.2000    
IPC:
A61K 31/00 (2006.01), A61K 31/4188 (2006.01), A61K 31/4245 (2006.01)
Applicants: TAKEDA CHEMICAL INDUSTRIES, LTD. [JP/JP]; 1-1, Doshomachi 4-chome, Chuo-ku, Osaka-shi, Osaka 541-0045 (JP) (For All Designated States Except US).
OJIMA, Mami [JP/JP]; (JP) (For US Only).
KITAYOSHI, Takahito [JP/JP]; (JP) (For US Only).
MIYAMOTO, Masaomi [JP/JP]; (JP) (For US Only)
Inventors: OJIMA, Mami; (JP).
KITAYOSHI, Takahito; (JP).
MIYAMOTO, Masaomi; (JP)
Agent: TAKAHASHI, Shuichi; Osaka Plant of Takeda Chemical Industries, Ltd., 17-85, Jusohonmachi 2-chome, Yodogawa-ku, Osaka-shi, Osaka 532-0024 (JP)
Priority Data:
11/205877 21.07.1999 JP
Title (EN) PREVENTIVES FOR THE RECURRENCE OF CEREBROVASCULAR FAILURE AND AGENTS FOR AMELIORATING TROUBLES FOLLOWING CEREBROVASCULAR FAILURE AND INHIBITING PROGRESS THEREOF
(FR) METHODES PREVENTIVES CONTRE LA RECURRENCE D'UNE INSUFFISANCE CEREBROVASCULAIRE, ET AGENTS DESTINES A AMELIORER DES TROUBLES CAUSES PAR UNE INSUFFISANCE CEREBROVASCULAIRE ET A INHIBER LEUR EVOLUTION
Abstract: front page image
(EN)Preventives for the recurrence of cerebrovascular failure and agents for ameliorating troubles following cerebrovascular failure and inhibiting the progress thereof which contain compounds having an antagonism to angiotensin II, prodrugs thereof or salts of the same.
(FR)L'invention concerne des méthodes préventives contre la récurrence d'une insuffisance cérébrovasculaire, et des agents destinés à améliorer des troubles causés par une insuffisance cérébrovasculaire et à inhiber leur évolution. Ces méthodes mettent en oeuvre des composés antagonistes de l'angiotensine II, et des promédicaments ou sels desdits composés.
Designated States: AE, AG, AL, AM, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CN, CR, CU, CZ, DM, DZ, EE, GD, GE, HR, HU, ID, IL, IN, IS, JP, KG, KR, KZ, LC, LK, LR, LT, LV, MA, MD, MG, MK, MN, MX, MZ, NO, NZ, PL, RO, RU, SG, SI, SK, TJ, TM, TR, TT, UA, US, UZ, VN, YU, ZA.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GW, ML, MR, NE, SN, TD, TG).
Publication Language: Japanese (JA)
Filing Language: Japanese (JA)